Mizuho Securities Cuts Price Target on Abercrombie & Fitch (ANF) Following 2Q Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
UBS Remains Sidelined on Abercrombie & Fitch (ANF) Following 2Q - PT to $18
August 31, 2016 9:29 AM EDTUBS maintained a Neutral rating on Abercrombie & Fitch (NYSE: ANF), and cut the price target to $18.00 (from $22.00), following the company's 2Q earnings report. UBS lowered FY16 EPS estimates to 0.67 (from $0.74), compared to the Street's $0.80. The cut is based on SSS.
Analyst Michael Binetti... More
BMO Capital Cut Price Target on Abercrombie & Fitch (ANF) to $19 Following 2Q
August 31, 2016 9:21 AM EDTBMO Capital maintained a Market Perform rating on Abercrombie & Fitch (NYSE: ANF), and cut the price target to $19.00 (from $20.00), following the company's 2Q earnings report. ANF reported adjusted EPS of ($0.25) vs. the Street expectation of ($0.20). The miss came primarily from a lower-than-expected gross... More
Unusual 11 Mid-Day Movers 8/30: (RIGL) (KPTI) (RBA) Higher; (ANF) (CBK) (GIII) Lower
August 30, 2016 12:56 PM EDTRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) 50.8% HIGHER; announced that fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, met the primary endpoint in the first of two double-blind studies in the FIT Phase 3 clinical program for the treatment of adult chronic/persistent immune thrombocytopenia (ITP). The study (n=76) showed that 18% of patients receiving fostamatinib achieved a stable platelet response compared to none receiving a placebo control (p=0.0261).
Abercrombie & Fitch (NYSE: ANF) 28.5% LOWER; reported Q2 EPS of ($0.25), $0.05 worse than the analyst estimate of... More
Pre-Open Stock Movers 08/30: (RIGL) (RBA) (MDLZ) Higher; (GIII) (ANF) (HSY) Lower (more...)
August 30, 2016 9:07 AM EDTToday's Pre-Open Stock Movers
Bonanza Creek Energy, Inc. (NYSE: BCEI) 24.2% HIGHER; announces that it has been notified by The New York Stock Exchange (NYSE) that it is no longer in compliance with certain continued listing... More
Abercrombie & Fitch's (ANF) Flagship, Tourist Locations Pressured Q2 Results Amid Light Traffic - Stifel
August 30, 2016 8:40 AM EDTStifel offered some initial takeaways from Abercrombie & Fitch's (NYSE: ANF) Q2 results and revised outlook. Stifel rates ANF at Buy... More
Wall St. weighed by Apple but banks shine on
August 30, 2016 7:40 AM EDTBy Rodrigo Campos
NEW YORK (Reuters) - Apple Inc was the largest weight on U.S. stock indexes on Tuesday after antitrust regulators ordered the company to pay about $14.5 billion in back taxes to the Irish government, but gains in bank shares partly offset the decline.
The S&P 500 fell for the fourth time in five sessions, but was still within 1 percent of its record closing high set earlier this month. Cyclical sectors, which are expected to perform better in an expanding economy, have taken the lead in the past few weeks as economic data paints a... More
Abercrombie & Fitch (ANF) Misses Q2 EPS by 5c
August 30, 2016 7:32 AM EDTAbercrombie & Fitch (NYSE: ANF) reported Q2 EPS of ($0.25), $0.05 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $783.2 million versus the consensus estimate of $782.1 million.
Comps fell 4 percent, versus an estimated 3.8 percent drop.
Fiscal 2016 Outlook
For fiscal 2016, the company now... More
Trading Radar for 8/30: Abercrombie & Fitch (ANF), Palo Alto Networks (PANW), Veeva Systems (VEEV) Report
August 29, 2016 2:58 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
9:00am EDT
Earnings:
Abercrombie & Fitch (ANF) puts more active than calls into Q2 and outlook
August 29, 2016 2:40 PM EDTAbercrombie & Fitch (NYSE: ANF) September 18 and 21 puts are active on total put volume of 25K contracts (18K calls) into the expected release of Q2 results on August 30. September weekly call option implied volatility is at 140, September is at 71, October is at 49; compared to its 52-week range of 33 to 75.
... MoreAbercrombie & Fitch (ANF) straddle expensive into Q2 and outlook
August 26, 2016 3:02 PM EDTAbercrombie & Fitch (NYSE: ANF) September weekly 22.50 straddle priced for movement of 11% into Q2 on August 30
... More